After a two year hiatus, Acumen has been re-appointed to work with Converge Challenge, Scotland’s leading company creation competition and entrepreneurial development programme for staff, students and recent graduates of Scottish Universities and Research Institutes. Converge Challenge represents all of Scotland’s Universities and Research Institutes, demonstrating a strong collaborative enterprise agenda in Scotland. The programme …
Griffith University’s ground-breaking Institute for Glycomics in Queensland increases microarray throughput for new frontier in drug and vaccine discovery.
Holographic 3D imaging is advancing the frontiers of biomedical science and will help speed up the diagnoses of many debilitating disease states
Edinburgh, 18th February 2016: Arrayjet, the Scottish-based microarray instrumentation company, has won a £150,000 contract with Neuchâtel, Switzerland-headquartered, Philip Morris Products, SA (PMP), a wholly-owned subsidiary of Philip Morris International, Inc. (PMI), the world’s leading tobacco company.
Acumen has been working with an academic start-up business at the University of Edinburgh which is looking to find a cure for the debilitating hearing condition of Tinnitus, which affects millions of people, globally.
The company behind ‘Deep Heat’, one of the UK’s iconic healthcare brands, has embarked on a collaboration with the Edinburgh Complex Fluids Partnership (ECFP) based at the University of Edinburgh, to research ways that further improve the production processes and operational efficiencies across its range of topically applied products.
Edinburgh imaging company creates world’s first 3D hologram of a human internal organ, the liver, from patient data, including visual information about arteries, tissue and other material.
